{"id":"NCT03936387","sponsor":"Boston Children's Hospital","briefTitle":"Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management: A Pilot Study","officialTitle":"Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management: A Pilot Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-07-01","primaryCompletion":"2019-09-01","completion":"2019-09-12","firstPosted":"2019-05-03","resultsPosted":"2021-04-05","lastUpdate":"2021-04-05"},"enrollment":10,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Pain, Postoperative"],"interventions":[{"type":"DRUG","name":"Ropivacaine","otherNames":["Naropin"]}],"arms":[{"label":"Bilateral erector spinae blocks","type":"EXPERIMENTAL"}],"summary":"Overall Aim: To evaluate the feasibility and potential benefits of investigating bilateral continuous erector spinae blocks (BESB) for postoperative pain management in a small cohort of children undergoing surgical sternotomy prior to planning an appropriately powered, randomized, controlled trial of the same.\n\nHypothesis: The investigators' primary hypothesis is that utilizing bilateral erector spinae blocks for post-sternotomy pain is a feasible intervention for consideration in a larger trial by demonstrating a 75% or greater successful intervention completion rate without any major adverse outcomes.","primaryOutcome":{"measure":"Number of Participants Who Completed a Successful Intervention With No Major Adverse Events","timeFrame":"48 hours","effectByArm":[{"arm":"Bilateral Erector Spinae Blocks","deltaMin":10,"sd":null}],"pValues":[]},"eligibility":{"minAge":"3 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":10},"commonTop":[]}}